Relmada Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $1.7M | $8.5M | $22.5M | $25.6M | $3.5M | $1.8M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $2.5M | $9.3M | $24.0M | $25.7M | $3.6M | $18.4K |
| Property, Plant & Equipment | $2.3K | $531.3K | $23.9K | $9.8K | $8.5K | — |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $2.8M | $10.2M | $24.4M | $25.8M | $3.6M | $18.4K |
| Liabilities | ||||||
| Accounts Payable | $529.6K | $1.3M | $835.3K | $746.1K | $180.3K | $7.0K |
| Total Current Liabilities | $1.4M | $3.1M | $15.6M | $26.8M | $21.5M | $7.0K |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $1.4M | $3.2M | $15.6M | $26.9M | $21.6M | $3.7M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-85.4M | $-79.1M | $-76.1M | $-55.3M | — | — |
| Total Stockholders' Equity | $1.5M | $7.0M | $8.8M | $-1.1M | $-17.9M | $-3.7M |